Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Peter Szaniszlo is active.

Publication


Featured researches published by Peter Szaniszlo.


Cytometry Part A | 2004

Getting the Right Cells to the Array: Gene Expression Microarray Analysis of Cell Mixtures and Sorted Cells

Peter Szaniszlo; Nan Wang; Mala Sinha; Lisa M. Reece; James W. Van Hook; Bruce A. Luxon; James F. Leary

Most biological samples are cell mixtures. Some basic questions are still unanswered about analyzing these heterogeneous samples using gene expression microarray technology (MAT). How meaningful is a cell mixtures overall gene expression profile (GEP)? Is it necessary to purify the cells of interest before microarray analysis, and how much purity is needed? How much does the purification itself distort the GEP, and how well can the GEP of a small cell subset be recovered?


DNA Repair | 2013

Activation of cellular signaling by 8-oxoguanine DNA glycosylase-1-initiated DNA base excision repair

Peter German; Peter Szaniszlo; Gyorgy Hajas; Zsolt Radak; Attila Bacsi; Tapas K. Hazra; Muralidhar L. Hegde; Xueqing Ba; Istvan Boldogh

Accumulation of 8-oxo-7,8-dihydroguanine (8-oxoG) in the DNA results in genetic instability and mutagenesis, and is believed to contribute to carcinogenesis, aging processes and various aging-related diseases. 8-OxoG is removed from the DNA via DNA base excision repair (BER), initiated by 8-oxoguanine DNA glycosylase-1 (OGG1). Our recent studies have shown that OGG1 binds its repair product 8-oxoG base with high affinity at a site independent from its DNA lesion-recognizing catalytic site and the OGG1•8-oxoG complex physically interacts with canonical Ras family members. Furthermore, exogenously added 8-oxoG base enters the cells and activates Ras GTPases; however, a link has not yet been established between cell signaling and DNA BER, which is the endogenous source of the 8-oxoG base. In this study, we utilized KG-1 cells expressing a temperature-sensitive mutant OGG1, siRNA ablation of gene expression, and a variety of molecular biological assays to define a link between OGG1-BER and cellular signaling. The results show that due to activation of OGG1-BER, 8-oxoG base is released from the genome in sufficient quantities for activation of Ras GTPase and resulting in phosphorylation of the downstream Ras targets Raf1, MEK1,2 and ERK1,2. These results demonstrate a previously unrecognized mechanism for cellular responses to OGG1-initiated DNA BER.


PLOS ONE | 2011

Carcinoma matrix controls resistance to cisplatin through talin regulation of NF-kB.

Karen E. Eberle; Hope A. Sansing; Peter Szaniszlo; Vicente A. Resto; Allison L. Berrier

Extracellular matrix factors within the tumor microenvironment that control resistance to chemotherapeutics are poorly understood. This study focused on understanding matrix adhesion pathways that control the oral carcinoma response to cisplatin. Our studies revealed that adhesion of HN12 and JHU012 oral carcinomas to carcinoma matrix supported tumor cell proliferation in response to treatment with cisplatin. Proliferation in response to 30 µM cisplatin was not observed in HN12 cells adherent to other purified extracellular matrices such as Matrigel, collagen I, fibronectin or laminin I. Integrin β1 was important for adhesion to carcinoma matrix to trigger proliferation after treatment with cisplatin. Disruption of talin expression in HN12 cells adherent to carcinoma matrix increased cisplatin induced proliferation. Pharmacological inhibitors were used to determine signaling events required for talin deficiency to regulate cisplatin induced proliferation. Pharmacological inhibition of NF-kB reduced proliferation of talin-deficient HN12 cells treated with 30 µM cisplatin. Nuclear NF-kB activity was assayed in HN12 cells using a luciferase reporter of NF-kB transcriptional activity. Nuclear NF-kB activity was similar in HN12 cells adherent to carcinoma matrix and collagen I when treated with vehicle DMSO. Following treatment with 30 µM cisplatin, NF-kB activity is maintained in cells adherent to carcinoma matrix whereas NF-kB activity is reduced in collagen I adherent cells. Expression of talin was sufficient to trigger proliferation of HN12 cells adherent to collagen I following treatment with 1 and 30 µM cisplatin. Talin overexpression was sufficient to trigger NF-kB activity following treatment with cisplatin in carcinoma matrix adherent HN12 cells in a process disrupted by FAK siRNA. Thus, adhesions within the carcinoma matrix create a matrix environment in which exposure to cisplatin induces proliferation through the function of integrin β1, talin and FAK pathways that regulate NF-kB nuclear activity.


Cytometry Part A | 2006

Scanning Cytometry with a LEAP: Laser-Enabled Analysis and Processing of Live Cells In Situ

Peter Szaniszlo; William A. Rose; Nan Wang; Lisa M. Reece; Tamara V. Tsulaia; Elie G. Hanania; Cornelis J. Elferink; James F. Leary

Scanning cytometry now has many of the features (and power) of multiparameter flow cytometry while keeping its own advantages as an imaging technology. Modern instruments combine capabilities of scanning cytometry with the ability to manipulate cells. A new technology, called LEAP™ (laser‐enabled analysis and processing), offers a unique combination of capabilities in cell purification and selective macromolecule delivery (optoinjection).


International Immunopharmacology | 2009

Effects of Colostrinin™ on gene expression-transcriptomal network analysis

Peter Szaniszlo; Peter German; Gyorgy Hajas; David Saenz; Mitchell Woodberry; Marian L. Kruzel; Istvan Boldogh

Colostrinin (CLN) is a uniform mixture of low-molecular weight proline-rich polypeptides isolated from the mothers first milk, colostrum. Exposure of cells to CLN decreases intracellular levels of reactive oxygen species by regulating glutathione metabolism and modulating activities of antioxidant enzymes and mitochondrial function. It also inhibits beta amyloid-induced apoptosis and induces neurite outgrowth of pheochromocytoma cells. Administration of CLN to Alzheimers disease patients has resulted in a stabilizing effect on cognitive function. We analyzed CLN-induced gene expression changes using high-density oligonucleotide arrays and transcriptomal network analysis. We found that CLN elicited highly complex and multiphasic changes in the gene expression profile of treated cells. CLN treatment affected a total of 58 molecular networks, 27 of which contained at least 10 differentially expressed genes. Here we present CLN-modulated gene networks as potential underlying molecular mechanisms leading to the reported effects of CLN on cellular oxidative state, chemokine and cytokine production, and cell differentiation, as well as on pathological processes like allergy, asthma, Alzheimers, and other neurological diseases. Based on our results, we also predict possible modulatory effects of CLN on adipocytokine gene networks that play a crucial role in the pathobiology of diabetes, cardiovascular disorders, obesity, and inflammation. Taken together, CLN-altered gene expression networks presented here provide the molecular basis for previously described biological phenomena and predict potential fields of application for CLN in the prevention and treatment of diseases.


Oral Oncology | 2014

Silencing Met receptor tyrosine kinase signaling decreased oral tumor growth and increased survival of nude mice

X. Tao; Kristen S. Hill; Ivana Gaziova; Sarita K. Sastry; S. Qui; Peter Szaniszlo; Susan M. Fennewald; Vicente A. Resto; Lisa A. Elferink

OBJECTIVES The hepatocyte growth factor receptor (Met) is frequently overexpressed in Head and Neck Squamous Cell Carcinoma (HNSCC), correlating positively with high-grade tumors and shortened patient survival. As such, Met may represent an important therapeutic target. The purpose of this study was to explore the role of Met signaling for HNSCC growth and locoregional dissemination. MATERIALS AND METHODS Using a lentiviral system for RNA interference, we knocked down Met in established HNSCC cell lines that express high levels of the endogenous receptor. The effect of Met silencing on in vitro proliferation, cell survival and migration was examined using western analysis, immunohistochemistry and live cell imaging. In vivo tumor growth, dissemination and mouse survival was assessed using an orthotopic tongue mouse model for HNSCC. RESULTS We show that Met knockdown (1) impaired activation of downstream MAPK signaling; (2) reduced cell viability and anchorage independent growth; (3) abrogated HGF-induced cell motility on laminin; (4) reduced in vivo tumor growth by increased cell apoptosis; (5) caused reduced incidence of tumor dissemination to regional lymph nodes and (6) increased the survival of nude mice with orthotopic xenografts. CONCLUSION Met signaling is important for HNSCC growth and locoregional dissemination in vivo and that targeting Met may be an important strategy for therapy.


Proceedings of SPIE - The International Society for Optical Engineering | 2001

High-throughput cell analysis and sorting technologies for clinical diagnostics and therapeutics

James F. Leary; Lisa M. Reece; Peter Szaniszlo; Tarl W. Prow; Nan Wang

A number of theoretical and practical limits of high-speed flow cytometry/cell sorting are important for clinical diagnostics and therapeutics. Three applications include: (1) stem cell isolation with tumor purging for minimal residual disease monitoring and treatment, (2) identification and isolation of human fetal cells from maternal blood for prenatal diagnostics and in-vitro therapeutics, and (3) high-speed library screening for recombinant vaccine production against unknown pathogens.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2014

Temporal characterization of lymphatic metastasis in an orthotopic mouse model of oral cancer

Peter Szaniszlo; Susan M. Fennewald; Suimin Qiu; Carla Kantara; Tuya Shilagard; Gracie Vargas; Vicente A. Resto

The overall mortality rate in cases of head and neck squamous cell carcinoma (HNSCC) has not improved over the past 30 years, mostly because of the high treatment failure rate among patients with regionally metastatic disease. To better understand the pathobiologic processes leading to lymphatic metastasis development, there is an urgent need for relevant animal models.


Biomedical optics | 2005

Subtractive clustering analysis: a novel data mining method for finding cell subpopulations

Jacob N. Smith; Lisa M. Reece; Peter Szaniszlo; Rosemary C. Leary; James F. Leary

A novel data mining program called “subtractive clustering” picks out the most important differences between two or more flow cytometry listmode data files. While making no assumptions about the data, the program uses a variable weight and skew metric in the determination of bin size allowing for subtractive clustering of data without the need for bit-reduction or projection. In contrast, other subtraction methods, such as channel-by-channel subtraction, are dependent upon dimensionality and resolution, which can lead to an overestimation of positive cells because they do not account for the overall distribution of the test and control data sets. By taking into account human visual inspection of the data it is possible for the experimenter to choose an optimal subtraction by choosing an appropriate weight and skew metric, but without allowing direct modification of the results. By maximizing a bin size which can still differentiate clusters, it is possible to minimize computation while still removing data. The choice of control weight allows for different levels of bin destruction during the subtraction stage, the smaller the number the more conservative the subtraction, the larger, the more liberal. Three data sets illustrate full dimensional subtraction, single step biological data and multi-stage subtraction to show definitive test results. Subtractive clustering was able to conservatively remove control information leaving populations of interest. Subtractive clustering provides a powerful comparison of clusters and is a first step for finding non-obvious (hidden) differences and minimizing human prejudice during the analysis.


Experimental Biology and Medicine | 1997

Novel Activation of γ-Interferon in Nonimmune Cells during Human Cytomegalovirus Replication

Istvan Boldogh; T. K. Bui; Peter Szaniszlo; Wade A. Bresnahan; Thomas Albrecht; Thomas K. Hughes

Abstract This is the first study documenting the induction of γ-interferon (IFN–γ) in human embryonic fibroblasts during human cytomegalovirus (HCMV) replication. Infection of cells with HCMV resulted in the consistent production of IFN-γ RNA, as determined by RT-PCR and Northern blot analysis. Western blot analysis of cell lysates and immunoprecipitates from the cultural fluids of infected cells demonstrated the presence of IFN-γ at the protein level. Induction of IFN-γ required infectious HCMV, since high-dose ultraviolet inactivation of the virus stock eliminated IFN-γ production. Further, IFN-γ induction appears to be a late event in the virus replication cycle, since inhibition of HCMV DNA synthesis (e.g., phosphonoacetic acid) blocked the increase in IFN-γ. Soluble factor(s) released from HCMV-infected cells apparently did not contribute to the induction of IFN-γ, since virus stocks from which virus had been removed by sedimentation did not induce production of IFN-γ. The appearance of IFN-γ at late stages of HCMV infection and its elimination in the presence of an inhibitor (Actinomycin D) of RNA synthesis indicate a true transcriptional induction of this lymphokine at the RNA and protein levels. The significance of IFN-y production with regard to the replication and pathogenesis of HCMV in vitro and In vivo will require further investigation.

Collaboration


Dive into the Peter Szaniszlo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Istvan Boldogh

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Nan Wang

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Vicente A. Resto

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Gyorgy Hajas

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Peter German

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

David Saenz

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Jacob N. Smith

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Susan M. Fennewald

University of Texas Medical Branch

View shared research outputs
Researchain Logo
Decentralizing Knowledge